fda compounded semaglutide enforcement news The growing availability of GLP-1 weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. Link in comments⬇️ FDA Warns of Dosing Errors

Your provider can offer prescription anti-nausea medications or adjust your treatment plan to match your tolerance

Overall prescribing rates (GLP-1 RA prescriptions as a proportion of all prescriptions) increased by more than one percentage point from December 2025 to March 2026 (+15.0%), representing the largest quarter-over-quarter percentage point increase observed since the start of the study period in 2019

Henry Meds ships to nearly every state, giving most US patients access regardless of location

This creates a significant opportunity for beverage innovation built around natural ingredients that support the bodys own metabolic signaling pathways, including GLP-1-related physiology